Analysis of clinicopathological characteristics and prognostic factors of early‐stage human epidermal growth factor receptor 2 (HER2)‐low breast cancer: Compared with HER2‐0 breast cancer

PURPOSE: To investigate the clinicopathological characteristics and prognostic factors of early‐stage breast cancer (EBC) with human epidermal growth factor receptor 2 (HER2)‐low expression. METHODS: The clinicopathological data and follow‐up information of EBC patients with HER2‐low and HER2‐0 expr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Qian, Yang, Fan, Liu, YinHua, Zhang, Hong, Zhang, Shuang, Xin, Ling, Xu, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587975/
https://www.ncbi.nlm.nih.gov/pubmed/37772432
http://dx.doi.org/10.1002/cam4.6571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587975/
https://www.ncbi.nlm.nih.gov/pubmed/37772432
http://dx.doi.org/10.1002/cam4.6571

Ejemplares similares